BioXcel Therapeutics, Inc. announced that it has entered into a securities purchase agreement with investors in a registered direct offering of 3,054,609 shares of common stock, par value $0.001 per share, and accompanying warrants to purchase up to 3,054,609 shares of Common Stock at a combined offering price of $2.901 per Share.
March 25, 2024
· 5 min read